Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medivolve Cancels Agreement to Acquire Karland Health; Completes Shares for Debt Settlement
Medivolve Inc.February 19, 2021 GMT
TORONTO, Feb. 19, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) announces the cancellation of the agreement to acquire 100% of Karland Health, LLC. As noted in the initial press release dated February 11th, 2021, the completion of the transaction to acquire Karland Health was subject to customary closing conditions, including due diligence to the satisfaction of Medivolve. After completing further due diligence, management determined that the acquisition of Karland Health would not be sufficiently accretive for the Company.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Boston Private Named Industry’s Best for Client Service by Private Asset Management
February 18, 2021 GMT
BOSTON (BUSINESS WIRE) Feb 18, 2021
Boston Private, a leading provider of integrated wealth management, trust and banking services, today announced that the company has won the 2021 Private Asset Management (PAM) Award for Best Private Wealth Manager for Client Service among wealth managers with more than $5 billion in assets under management.
ADVERTISEMENT
Fund Intelligence’s PAM Awards recognize the top-performing firms serving the private wealth community. Boston Private was selected for this award based on client service, client longevity, and the firm’s overall growth within the past year. Judging was conducted by an independent panel of industry experts and was based on both qualitative and quantitative performance measures.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Longeveron Inc. Announces the Appointment of Prominent Biotech, Capital Markets and Corporate .
LongeveronFebruary 18, 2021 GMT
MIAMI, Feb. 18, 2021 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the appointments of Douglas Losordo, M.D., Erin Borger, and Cathy Ross to the Company’s Board of Directors.
Douglas Losordo, MD Dr. Losordo has worked in the biotech industry for over twenty years, most recently serving as Executive Vice President, Head of Research and Development and Chief Medical Officer of KBP Biosciences Inc. Dr. Losordo was previously the Executive Vice President, Global Head of Research and Development, Chief Medical Officer of Caladrius Biosciences (Nasdaq: CLBS), a clinical-stage bio
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medigus Forms Joint Venture for the Development of Urban and Logistics Electric Vehicles with .
Medigus LtdFebruary 19, 2021 GMT
Former designer of Italian vehicles manufacturer, Amir Zaid and leading manufacturer of high-end scooters, E-mobility and Skiing Machines, Weijian Zhou will join Medigus, via its wholly owned subsidiary Charging Robotics, in the Joint Venture
OMER, Israel, Feb. 19, 2021 (GLOBE NEWSWIRE) Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions and innovative technology, announced today the signing of a definitive agreement to form a joint venture, NewCo, for the development and commercialization of urban and logistics EV micro-mobility vehicles for “last mile” delivery, and cargo. The signing of the definitive agreement relating to NewCo relates to the prior announcement in November 2020 regarding the execution of the non-bin